NEW YORK( GenomeWeb) – HTG Molecular, which recently filed for a planned initial public offering, has raised more than $18 million, it said in a regulatory document on Friday. 

Through a spokesperson, the Tucson, Ariz.-based molecular diagnostics firm declined to comment on the financing. It said in a document filed with the US Securities and Exchange Commission that 19 investors have contributed to the offering, though it did not identify them. It also did not say how it plans to use proceeds from the offering. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.